In this video, Crystal A. Gadegbeku, MD, FASN, discusses some of the late-breaking clinical trials in broad and specific kidney disease treatments presented at ASN Kidney Week.“We are really in an era ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...

Researchers at The Johns Hopkins Medicine say they have developed a new electronic medical records-based tool that should help doctors predict which patients are most at risk of losing a transplanted ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So that's one of our big focuses, and also, ...

Rates of the disease have been rising for decades, driven in part by diabetes and high blood pressure. By Nina Agrawal The number of adults with chronic kidney disease is growing, according to a study ...

Jesse Eisenberg at the "Batman v Superman: Dawn of Justice" premiere (Credit: Justin Tallis/AFP via Getty Images) “I’m actually donating my kidney in six weeks,” Jesse Eisenberg said on “The Today ...

Hundreds gathered at Lone Star Park in Grand Prairie for the National Kidney Foundation’s annual walk, raising awareness and funds to fight kidney disease. Woman blames Donald Trump for her $40,000 ...

You should limit sodium to less than 2,300 milligrams daily to decrease fluid retention and blood pressure. Eat no more than 800-1,000 milligrams of phosphorus daily to prevent bone and heart ...

Nine out of 10 people with chronic kidney disease only find out when it progresses to later stages. Here’s what we know about its risk factors—and why there's new reason to hope for more effective ...

Aug 19 (Reuters) - Canada has approved Novo Nordisk's (NOVOb.CO), opens new tab diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of kidney failure and ...

Dr. Peirce invited Kuhn to co-lecture on Renal Replacement Therapy for second-year medical students. The session, held in Fall 2023, featured hands-on props including dialyzers, dialysis needles, ...

Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...